A chimeric promoter to render a gene responsive to pathogens, obtained by a method comprising inserting at least one cis-acting element sufficient to direct pathogen-elicitor-induced expression, pathogen-infection-induced expression, or both, of an operably linked nucleic acid, into the promoter of said gene, wherein
- (1) the at least one cis-acting element mediates induction of local gene expression in plants upon the pathogen elicitor treatment, the pathogen infection, or both, to between 10-fold and 15-fold and wherein the at least one cis-acting element comprises
- four copies of SEQ ID NO:11;
- or
- the combination of one copy of SEQ ID NO:11 followed by one copy of SEQ ID NO:3 or SEQ ID NO:4;
- or
- the combination of four copies of SEQ ID Nall followed by four copies of SEQ ID NO:3 or SEQ ID NO:4;
- or
- the combination of four copies of SEQ ID NO:7 followed by four copies of SEQ ID NO:11;
- or
- (2) the at least one cis-acting element mediates induction of local gene expression in plants upon the pathogen elicitor treatment, the pathogen infection, or both to between 15-fold and 81-fold and the at least one cis-acting element comprises
- two copies of SEQ ID NO:
- 11;
- or
- a combination of one copy of SEQ ID NO:
- 11 and one copy of SEQ ID NO:
- 7;
- or
- the combination of four copies of SEQ ID NO:11 followed by four copies of SEQ ID NO:7;
- or
- the combination of two copies of SEQ ID NO:3 or SEQ ID NO:4 followed by two copies of SEQ ID NO:11;
- or
- (3) the at least one cis-acting element comprises
- at least one copy of the nucleotide sequence of SEQ ID NO:
- 11 and at least one copy of the nucleotide sequence of SEQ ID NO:1 or 2;
- or
- at least one copy of the nucleotide sequence of SEQ ID NO:
- 11 and at least one copy of the nucleotide sequence of SEQ ID NO:7;
- or
- two copies of the nucleotide sequence of SEQ ID NO:
- 11 and two copies of the nucleotide sequence of SEQ ID NO:
- 7;
- or
- at least one copy of the nucleotide sequence of SEQ ID NO:
- 11 and at least one copy of the nucleotide sequence of SEQ ID NO:3 or 4;
- or
- (4) the at least one cis-acting element comprises:
- (i) two or more cis-acting elements sufficient to direct the pathogen-elicitor-induced expression of the nucleic acid sequence, the pathogen-infection-induced expression of the nucleic acid, or both, wherein at least one of the two or more cis-acting elements consists of the nucleotide sequence of SEQ ID NO:11, and
- (ii) a cis-acting element having the nucleotide sequence selected from the group consisting of SEQ ID NO:5, 6, 8, 9, 10, 12 and 13.